advanced metastatic melanoma

Pharma

Novartis' targeted lung cancer combo picks up EU approval

With a new green light in Europe in lung cancer, Novartis just took another step in expanding the market for its targeted Tafinlar-plus-Mekinist combination therapy.

Eric Sagonowsky Apr 5, 2017 9:17am

Roche leapfrogs to PhIII with melanoma-fighting Tecentriq combos into pivotal trials

Nov 7, 2016 9:01am

Japan's Oncolys plans to test Imlygic rival in melanoma

Sep 5, 2016 12:13pm

SkinJect reaches deal with UPitt on skin cancer treatment

Aug 9, 2016 9:15am

Experimental 'universal’ cancer vaccine tested in early trial

Jun 8, 2016 9:18am